Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trialHiddo J.L. Heerspink, Janet B. McGill, Helen M. Colhoun et al.|Diabetes Research and Clinical Practice|2023Cited by 57
875-P: Baseline Characteristics for FINE-ONE—A Randomized Phase III Trial Assessing Finerenone in People with T1D and CKDHiddo J.L. Heerspink, Andreas L. Birkenfeld, David Cherney et al.|Diabetes|2025Cited by 0